Literature DB >> 7188182

Membrane fusion activity of influenza virus.

J White, J Kartenbeck, A Helenius.   

Abstract

A simple assay is described to monitor fusion between fowl plague virus (FPV, an avian influenza A virus) and liposomes which allows the simultaneous quantitation of both lytic and non-lytic fusion events. As in fusion between viruses and the plasma membrane and in FPV-induced cell-cell fusion, the reaction only occurs at pH 5.5 or below, and it is fast, highly efficient, and essentially non-lytic when fresh virus and liposomes are used. The fusion occurs over a broad temperature range, and has no requirement for divalent cations. The fusion factor of influenza virus is a hemagglutinin (HA) spike which protrudes from the virus membrane and which is also responsible for virus binding to the host cell. The finding that fusion occurs as efficiently with liposomes containing or lacking virus receptor structures, further emphasizes the remarkable division of labor in the HA molecule: the receptor-binding sites are located in the globular HA1 domains and the fusion activation peptide is found at the N-terminal of HA2 in the stem region of the protein. The mechanism of fusion is discussed in terms of the three-dimensional structure of the HA and the conformational change which the protein undergoes at the fusion pH optimum.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7188182      PMCID: PMC553023          DOI: 10.1002/j.1460-2075.1982.tb01150.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin.

Authors:  R Fang; W Min Jou; D Huylebroeck; R Devos; W Fiers
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

3.  Adsorptive endocytosis of Semliki Forest virus.

Authors:  M Marsh; A Helenius
Journal:  J Mol Biol       Date:  1980-09-25       Impact factor: 5.469

4.  pH-dependent hemolysis by influenza, Semliki, Forest virus, and Sendai virus.

Authors:  J Lenard; D K Miller
Journal:  Virology       Date:  1981-04-30       Impact factor: 3.616

5.  Hemolytic activity of the envelope glycoproteins of western equine encephalitis virus in reconstitution experiments.

Authors:  K Yamamoto; K Suzuki; B Simizu
Journal:  Virology       Date:  1981-03       Impact factor: 3.616

6.  Influenza viruses cause hemolysis and fusion of cells.

Authors:  R T Huang; R Rott; H D Klenk
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

7.  Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

Authors:  C D Richardson; A Scheid; P W Choppin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

8.  Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus.

Authors:  M J Gething; J Bye; J Skehel; M Waterfield
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

9.  Haemolysis by two alphaviruses: Semliki Forest and Sindbis virus.

Authors:  P Väänänen; L Kääriäinen
Journal:  J Gen Virol       Date:  1979-06       Impact factor: 3.891

10.  Preparation and properties of various salt forms of plant phosphatidyl inositols.

Authors:  H E Carter; E J Weber
Journal:  Lipids       Date:  1966-01       Impact factor: 1.880

View more
  103 in total

1.  Formation and characterization of the trimeric form of the fusion protein of Semliki Forest Virus.

Authors:  D L Gibbons; A Ahn; P K Chatterjee; M Kielian
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins.

Authors:  Kye-Il Joo; April Tai; Chi-Lin Lee; Clement Wong; Pin Wang
Journal:  Microsc Res Tech       Date:  2010-09       Impact factor: 2.769

3.  Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEM.

Authors:  J Charles Whitbeck; Yi Zuo; Richard S B Milne; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Formation of ion channels by colicin B in planar lipid bilayers.

Authors:  J O Bullock; S K Armstrong; J L Shear; D P Lies; M A McIntosh
Journal:  J Membr Biol       Date:  1990-03       Impact factor: 1.843

5.  Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein.

Authors:  P Levy-Mintz; M Kielian
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Monoclonal antibodies detect different forms of influenza virus hemagglutinin during viral penetration and biosynthesis.

Authors:  T Bächi; W Gerhard; J W Yewdell
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

7.  Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.

Authors:  R W Doms; R Blumenthal; B Moss
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus.

Authors:  G Whittaker; I Kemler; A Helenius
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

9.  Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation.

Authors:  Y Gaudin; C Tuffereau; P Durrer; A Flamand; R W Ruigrok
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis.

Authors:  Sara B Sieczkarski; Gary R Whittaker
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.